EX-99.1 2 ea167736ex99-1_bioplusacq.htm JOINT FILING AGREEMENT, DATED AS OF NOVEMBER 2, 2022, BY AND AMONG THE REPORTING PERSONS

EXHIBIT 99.1

 

JOINT FILING AGREEMENT

 

Each of the undersigned hereby acknowledges and agrees, in compliance with the provisions of Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, that the Schedule 13G to which this Agreement is attached as an Exhibit, and any amendments thereto, will be filed with the Securities and Exchange Commission jointly on behalf of the undersigned. This Agreement may be executed in one or more counterparts.

 

Date: November 2, 2022

 

  CANTOR FITZGERALD SECURITIES
   
  By: /s/ Howard W. Lutnick
    Name: Howard W. Lutnick
    Title:    Chief Executive Officer
   
 

CANTOR FITZGERALD, L.P.

   
  By: /s/ Howard W. Lutnick
    Name: Howard W. Lutnick
    Title:    Chief Executive Officer
   
 

CF GROUP MANAGEMENT, INC.

   
  By: /s/ Howard W. Lutnick
    Name:  Howard W. Lutnick
    Title:    Chief Executive Officer
   
 

HOWARD W. LUTNICK

   
  By: /s/ Howard W. Lutnick
    Howard W. Lutnick.

 

[Schedule 13G – BioPlus Acquisition Corp. – Joint Filing Agreement – November 2022]